Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Plegridy™ (Peginterferon β-1a) Real World Effectiveness and Safety Observational Program

NCT02230969 is registered in ClinicalTrials.gov with Biogen as lead sponsor.

NCT NCT02230969
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02230969 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Plegridy™ (Peginterferon β-1a) Real World Effectiveness and Safety Observational Program
Lead sponsor
Biogen
Phase
Observational
Overall status
Completed
Start date
November 12, 2014
Completion date
January 20, 2022
Enrollment
1,208 (actual)
Sites
152

Conditions

As the registry lists them; a condition with its own page is linked.

relapsing forms of multiple sclerosis